Journal

Headline subscription prices can be misleading once feedback, membership discounts, VAT and stacked products are accounted for. The real first-year, five-year and PSQ/MSF-year cost...

Umbil has moved beyond a simple clinical chatbot into portfolio territory. The review needs to distinguish its rapidly expanding functions from a fully proven end-to-end appraisal ...

Does GP Tools' lower price and included feedback outweigh FourteenFish's more mature integrations and appraiser familiarity? The answer depends heavily on RCGP membership status an...

There is no single FourteenFish alternative, only the right alternative for your specific situation. Eight categories, an honest decision tree, and the critical caveat: several of ...

The two brands sound comparable and solve genuinely different problems. GP Tools is a structured appraisal toolkit. Umbil starts with daily clinical activity and attempts to turn i...

GP Tools may be the most credible low-cost direct alternative to the established appraisal platforms, priced at £39.99 a year with the first free. Its lower public profile means pr...

A seven-domain procurement rubric for any UK medical school evaluating an AI virtual-patient vendor: clinical content, patient fidelity, assessment validity, educational effect, fa...

AI reduces the marginal cost of an additional formative encounter. Saving actor costs is not the same as replacing the educational role trained simulated patients play. A full cost...

Virtual-patient practice identifies performance gaps; it does not necessarily repair the underlying knowledge or verify the management. A ten-step workflow from an unseen Simsbuddy...

Institutional buyers should choose according to the skills they need to teach, not the most impressive demonstration avatar. SimPatient, MedAscend and Oxford Medical Simulation com...

The published protocol for testing whether ChatGPT's direct PubMed connector improves evidence quality, not merely citation quantity: 100 to 150 questions across eleven clinical ca...

Connecting to Epic in the US does not mean the product can simply be switched on across NHS primary and secondary care. Sixteen adoption questions any NHS organisation would need a...